SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis

NCT04563520 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Hemophilia A

Interventions

DRUG: Emicizumab
DRUG: FEIBA
DRUG: rFVIIa

Sponsor

Emory University

Collaborators

[object Object]